Skip to main content

Click the link below to view the Sjögren's Foundation letter to the U.S. Food & Drug Administration regarding the abrupt shortage of hydroxychloroquine (Plaquenil).

Sjögren's Foundation Letter to FDA on Plaquenil Shortage

During this critical time, the Foundation absolutely recognizes the urgent and profound global need to find an effective treatment for COVID-19. However, we need to ensure there is awareness and consideration for Sjögren's patients, and other autoimmune disease patients, who currently depend on this life-saving medication. 

If you have experienced a shortage or refusal to refill of hydroxychloroquine (Plaquenil), please email DRUGSHORTAGES [at] fda [dot] hhs [dot] gov (DRUGSHORTAGES[at]fda[dot]hhs[dot]gov)Let your voice be heard that an increase supply is needed.